facebook linkedin twitter
FDA Panel Takes Up Tough Questions on J&J COVID-19 Boosters
Health
FDA Panel Takes Up Tough Questions on J&J COVID-19 Boosters

WASHINGTON (AP) — U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when — and whether using a competing brand for the second dose might provide better protection. The push for... Read More

Next on FDA's Agenda: Booster Shots of Moderna, J&J Vaccines
Health
Next on FDA's Agenda: Booster Shots of Moderna, J&J Vaccines

WASHINGTON (AP) — With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it's their turn. Federal... Read More

J&J Seeks US Clearance for COVID-19 Vaccine Booster Doses
Health
J&J Seeks US Clearance for COVID-19 Vaccine Booster Doses

WASHINGTON (AP) — Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans. J&J said it... Read More

Opioid Maker and Distributors Settle State Lawsuits for $26 Billion
Litigation
Opioid Maker and Distributors Settle State Lawsuits for $26 Billion
2021-07-23 20:15:27
by Tom Ramstack

A coalition of state attorneys general reached a $26 billion settlement with opioid maker Johnson & Johnson and three of its distributors this week. They blame the companies for a half-million deaths in the United States from overdoses and addictions... Read More

Justices Reject Johnson & Johnson Bid to Overturn $2B Talc Verdict
Supreme Court
Justices Reject Johnson & Johnson Bid to Overturn $2B Talc Verdict
2021-06-10 11:24:56
by TWN Staff

The Supreme Court this week decided to leave in place a $2 billion verdict in favor of women who claim they developed ovarian cancer from using Johnson & Johnson talc products. As is their custom, the justices did not comment Tuesday on... Read More

Johnson & Johnson Asks High Court to Void $2B Talc Verdict
Litigation
Johnson & Johnson Asks High Court to Void $2B Talc Verdict

WASHINGTON (AP) — Johnson & Johnson is asking for Supreme Court review of a $2 billion verdict in favor of women who claim they developed ovarian cancer from using the company's talc products. The case features an array of high-profile... Read More

Pharmaceutical Executives Suggest Annual COVID-19 Vaccinations
Health
Pharmaceutical Executives Suggest Annual COVID-19 Vaccinations
2021-04-19 14:18:13
by Tom Ramstack

Officials from the top U.S. pharmaceutical companies making the COVID-19 vaccine are saying vaccinated persons are likely to need booster shots within a year. In fact, they probably will need to get vaccinated yearly for the foreseeable future, similar to... Read More

J&J Vaccine to Remain in Limbo While Officials Seek Evidence
Health
J&J Vaccine to Remain in Limbo While Officials Seek Evidence

Johnson & Johnson's COVID-19 vaccine will remain in limbo for a while longer after government health advisers declared Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot — and... Read More

Biden Says Pause on J&J Shots Shows Gov't Putting Safety 1st
Health
Biden Says Pause on J&J Shots Shows Gov't Putting Safety 1st

WASHINGTON (AP) — President Joe Biden's COVID-19 vaccination campaign hit a snag when federal regulators recommended a "pause" in administering Johnson & Johnson shots. But the White House portrayed the action as important validation of his measured approach throughout the... Read More

US Recommends 'Pause' for J&J Vaccine Over Clot Reports
Health
US Recommends 'Pause' for J&J Vaccine Over Clot Reports

WASHINGTON (AP) — The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.In a joint statement Tuesday, the Centers for Disease Control and Prevention and the... Read More

FDA Says J&J 1-Dose Shot Prevents COVID; Final Decision Soon
Health
FDA Says J&J 1-Dose Shot Prevents COVID; Final Decision Soon

WASHINGTON (AP) — Johnson & Johnson's single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.  The Food... Read More

Johnson & Johnson 1-dose Shot Prevents COVID-19, But Less Than Some Others
Health
Johnson & Johnson 1-dose Shot Prevents COVID-19, But Less Than Some Others

Johnson & Johnson’s long-awaited vaccine appears to protect against COVID-19 with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. J&J said Friday that in the... Read More

Straight From The Well
scroll top